Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Morel

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Cancer Research|November 26, 2020
EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast CancersMélanie K Prodhomme, Roxane M Pommier, Camille Franchet, et al.
Hemasphere|July 31, 2024
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life studyAxel André, Lydia Montes, Damien Roos-Weil, et al.
Cell Reports|January 20, 2021
Loss of floor plate Netrin-1 impairs midline crossing of corticospinal axons and leads to mirror movementsOriane Pourchet, Marie-Pierre Morel, Quentin Welniarz, et al.
Cancer Cell|July 5, 2008
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescenceStéphane Ansieau, Jeremy Bastid, Agnès Doreau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 31, 2013
Mature Purkinje cells require the retinoic acid-related orphan receptor-α (RORα) to maintain climbing fiber mono-innervation and other adult characteristicsXiao Ru Chen, Nicolas Heck, Ann M Lohof, et al.
Annals of Hematology|November 5, 2024
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemiaCécile Tomowiak, Stéphanie Poulain, Morgane Nudel, et al.
Scientific Reports|March 26, 2017
Non cell-autonomous role of DCC in the guidance of the corticospinal tract at the midlineQuentin Welniarz, Marie-Pierre Morel, Oriane Pourchet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2015
TCL1 expression patterns in Waldenström macroglobulinemiaRichard Lemal, Sandrine Bard-Sorel, Laura Montrieul, et al.
Haematologica|May 27, 2014
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)Arnaud Jaccard, Raymond L Comenzo, Parameswaran Hari, et al.
Medicine|March 18, 2008
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patientsBenjamin Terrier, Arnaud Jaccard, Jean-Luc Harousseau, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Cancer Research|November 26, 2020
EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast CancersMélanie K Prodhomme, Roxane M Pommier, Camille Franchet, et al.
Hemasphere|July 31, 2024
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life studyAxel André, Lydia Montes, Damien Roos-Weil, et al.
Cell Reports|January 20, 2021
Loss of floor plate Netrin-1 impairs midline crossing of corticospinal axons and leads to mirror movementsOriane Pourchet, Marie-Pierre Morel, Quentin Welniarz, et al.
Cancer Cell|July 5, 2008
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescenceStéphane Ansieau, Jeremy Bastid, Agnès Doreau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 31, 2013
Mature Purkinje cells require the retinoic acid-related orphan receptor-α (RORα) to maintain climbing fiber mono-innervation and other adult characteristicsXiao Ru Chen, Nicolas Heck, Ann M Lohof, et al.
Annals of Hematology|November 5, 2024
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemiaCécile Tomowiak, Stéphanie Poulain, Morgane Nudel, et al.
Scientific Reports|March 26, 2017
Non cell-autonomous role of DCC in the guidance of the corticospinal tract at the midlineQuentin Welniarz, Marie-Pierre Morel, Oriane Pourchet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2015
TCL1 expression patterns in Waldenström macroglobulinemiaRichard Lemal, Sandrine Bard-Sorel, Laura Montrieul, et al.
Haematologica|May 27, 2014
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)Arnaud Jaccard, Raymond L Comenzo, Parameswaran Hari, et al.
Medicine|March 18, 2008
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patientsBenjamin Terrier, Arnaud Jaccard, Jean-Luc Harousseau, et al.
Pageof 16